Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Experimental Medicine|November 27, 2013
Nfil3-independent lineage maintenance and antiviral response of natural killer cellsMatthew A Firth, Sharline Madera, Aimee M Beaulieu, et al.
BMC Medical Education|July 13, 2017
Exploring intentions of physician-scientist trainees: factors influencing MD and MD/PhD interest in research careersJennifer M Kwan, Dania Daye, Mary Lou Schmidt, et al.
AIDS Research and Therapy|April 8, 2025
Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIVEric S Daar, Chloe Orkin, Paul E Sax, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
Clinical Evaluation of Drug-Drug Interactions with Obeldesivir, an Orally Administered Antiviral AgentChi-Chi Peng, Rita Humeniuk, Anuja Raut, et al.
Journal of Virology|August 30, 2022
Discovery and Genomic Characterization of a Novel Henipavirus, Angavokely Virus, from Fruit Bats in MadagascarSharline Madera, Amy Kistler, Hafaliana C Ranaivoson, et al.
Infection Control and Hospital Epidemiology|September 6, 2021
Increased rates of secondary bacterial infections, including <i>Enterococcus</i> bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19)Catherine DeVoe, Mark R Segal, Lusha Wang, et al.
Infection Control and Hospital Epidemiology|March 21, 2022
Prolonged silent carriage, genomic virulence potential and transmission between staff and patients characterize a neonatal intensive care unit (NICU) outbreak of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA)Sharline Madera, Nicole McNeil, Paula Hayakawa Serpa, et al.
Annals of Internal Medicine|December 22, 2025
Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized StudyAmy E Colson, Gordon E Crofoot, Peter J Ruane, et al.
The Lancet. Microbe|January 9, 2026
Implementation and outcomes of a rapid response genomic hospital epidemiology programme at an academic medical centre over 7 yearsVictoria T Chu, Natasha Spottiswoode, Ryan Ward, et al.
Pageof 2